Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experience (Q38334759)

2 September 2017

Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experience (English)

1 reference

2 September 2017

Philip A Kalra

1

1 reference

2 September 2017

1 June 2011

1 reference

2 September 2017

1 reference

2 September 2017

4

1 reference

2 September 2017

Suppl 1

1 reference

2 September 2017

i10-i13

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

2 September 2017

start time

3 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Iron management in end-stage renal disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Hapten inhibition of passive antidextran dextran anaphylaxis in guinea pigs. Role of molecular size in anaphylactogenicity and precipitability of dextran fractions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Ferric carboxymaltose in patients with heart failure and iron deficiency

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Evolution of iv iron compounds over the last century

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Update on adverse drug events associated with parenteral iron

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

The molecular formula and proposed structure of the iron-dextran complex, imferon

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Iron status and hemoglobin level in chronic renal insufficiency

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Safety of dextran in relation to other colloids--ten years experience with hapten inhibition.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4813791

Pretreatment with dextran 1 makes dextran 40 therapy safer

31 August 2018

1 reference

12 December 2020

Successful prevention of an anaphylactoid reaction to iron dextran

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%

1 reference

12 December 2020

Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease

1 reference

12 December 2020

Hematocrit level and associated mortality in hemodialysis patients

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDTPLUS/SFR042

0 references

PMC publication ID

4813791

1 reference

PMC publication ID

4813791

2 September 2017

PubMed publication ID

27045417

1 reference

PMC publication ID

4813791